| Literature DB >> 23781187 |
S Vandenbroucke1, G Crombez, D M L Van Ryckeghem, M Brass, S Van Damme, L Goubert.
Abstract
OBJECTIVE: This study aimed at developing an experimental paradigm to assess vicarious pain experiences. We further explored the putative moderating role of observer's characteristics such as hypervigilance for pain and dispositional empathy.Entities:
Keywords: empathy; hypervigilance for pain; observation of pain; synaesthesia for pain; vicarious pain
Year: 2013 PMID: 23781187 PMCID: PMC3678108 DOI: 10.3389/fnhum.2013.00265
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
An overview of all trial types (experiment 1 - experiment 2).
| % | 93.27% | 0.33% | 2.07% | 3.27% | 90.40% | 0.93% | 3.00% | 4.53% | 1.40% | 0.33% | 0.20% | 97.60% |
| % | 94.00% | 0.17% | 0.42% | 4.25% | 92.00% | 0.25% | 1.42% | 5.17% | 0.67% | 0.42% | 0.00% | 98.17% |
Voice key errors are not included.
Figure 1Example of a possible trial.
Mean scores and standard deviations of all measures (study 1).
| 1. RT incongruent trials | 784.48 (118.44) | 674.45 (74.34) | 736.07 (114.06) |
| 2. RT congruent trials | 719.79 (136.86) | 628.82 (70.88) | 679.76 (119.84) |
| 3. Intensity (0–10) | 4.46 (1.66) | 4.77 (1.65) | 4.6 (1.63) |
| 4. (Un)pleasantness | −1.43 (1.41) | −1.95 (0.76) | −1.66 (1.18) |
| 5. PVAQ | 39.62 (13.64) | 30.0 (10.52) | 35.39 (13.06) |
| 6. EC | 19.21 (3.38) | 17.91 (3.75) | 18.64 (3.53) |
| 7. FS | 21.29 (4.46) | 19.00 (4.77) | 20.28 (4.65) |
| 8. PD | 12.50 (6.16) | 15.82 (3.34) | 13.96 (5.30) |
PVAQ, Pain Vigilance and Awareness Questionnaire; EC, Empathic Concern; FS, Fantasy Scale; PD, Personal Distress; RT, Reaction times.
Pearson/spearman correlations of all measures (study 1).
| 1. RT incongruent trials | 0.91 | −0.17 | −0.05 | 0.03 | −0.23 | 0.17 | −0.51 |
| 2. RT congruent trials | − | −0.24 | −0.02 | 0.01 | −0.32 | 0.09 | −0.57 |
| 3. Intensity (0–10) | − | −0.62 | 0.41 | 0.12 | 0.26 | 0.53 | |
| 4. (Un)pleasantness | − | −0.41 | 0.22 | −0.43 | −0.24 | ||
| 5. PVAQ | − | 0.13 | 0.18 | −0.07 | |||
| 6. EC | − | 0.41 | 0.17 | ||||
| 7. FS | − | 0.04 | |||||
| 8. PD | − |
PVAQ, Pain Vigilance and Awareness Questionnaire; EC, Empathic Concern; FS, Fantasy Scale; PD, Personal Distress; RT, Reaction times.
p < 0.05;
p < 0.01.
Figure 2The relationship between hypervigilance for pain (PVAQ) and vicarious pain errors as moderated by group (study 1).
Mean scores and standard deviations (study 2).
| 1. RT incongruent trials | 711.07 (155.00) | 685.51 (86.72) | 702.12 (133.06) |
| 2. RT congruent trials | 681.10 (150.37) | 651.05 (58.46) | 670.59 (124.80) |
| 3. Intensity | 4.38 (2.31) | 3.86 (2.46) | 4.20 (2.31) |
| 4. (Un)pleasantness | −1.81 (1.16) | −1.5 (1.08) | −1.70 (1.12) |
| 5. PVAQ | 42.23 (14.14) | 42.00 (9.13) | 42.15 (12.36) |
| 6. EC | 21.62 (2.02) | 18 (4.58) | 20.35 (3.51) |
| 7. FS | 20.85 (4.63) | 19.57 (5.86) | 20.40 (4.98) |
| 8. PD | 14.54 (4.99) | 14.43 (5.22) | 14.50 (4.94) |
| 9. RHI | 753.77 (206.04) | 631.86 (199.73) | 711.10 (207.29) |
PVAQ, Pain Vigilance and Awareness Questionnaire; EC, Empathic Concern; FS, Fantasy Scale; PD, Personal Distress; RHI, Rubber Hand Illusion; RT, Reaction times.
Pearson/spearman correlations of all measures (study 2).
| 1. RT incongruent trials | 0.96 | −0.16 | 0.06 | 0.27 | −0.12 | 0.18 | −0.11 | 0.24 |
| 2. RT congruent trials | − | −0.07 | 0.10 | 0.33 | −0.14 | 0.18 | −0.10 | 0.23 |
| 3. Intensity | − | −0.61 | 0.10 | −0.18 | 0.17 | 0.24 | 0.16 | |
| 4. (Un)pleasantness | − | 0.01 | 0.02 | −0.07 | −0.21 | 0.11 | ||
| 5. PVAQ | − | 0.28 | 0.23 | 0.47 | 0.48 | |||
| 6. EC | − | 0.28 | 0.14 | 0.12 | ||||
| 7. FS | − | 0.06 | 0.39 | |||||
| 8. PD | − | 0.46 | ||||||
| 9. RHI | − |
PVAQ, Pain Vigilance and Awareness Questionnaire; EC, Empathic Concern; FS, Fantasy Scale; PD, Personal Distress; RHI, Rubber Hand Illusion; RT, Reaction times.
p < 0.05;
p < 0.01.
Figure 3The relationship between hypervigilance for pain (PVAQ) and vicarious pain errors as moderated by group (study 2).
Mean scores and standard deviations (overall analyses).
| 1. RT incongruent trials | 749.14 (139.64) | 678.76 (77.04) | 720.98 (122.60) |
| 2. RT congruent trials | 701.16 (142.09) | 637.47 (65.47) | 675.69 (120.75) |
| 3. intensity | 4.43 (1.96) | 4.42 (1.99) | 4.42 (1.95) |
| 4. (Un)pleasantness | −1.61 (1.29) | −1.78 (0.89) | −1.68 (1.14) |
| 5. PVAQ | 40.88 (13.68) | 34.67 (11.43) | 38.39 (13.06) |
| 6. EC | 20.37 (3.01) | 17.94 (3.96) | 19.40 (3.59) |
| 7. FS | 21.07 (4.46) | 19.22 (5.06) | 20.33 (4.74) |
| 8. PD | 13.48 (5.62) | 15.28 (4.08) | 14.20 (5.09) |
PVAQ, Pain Vigilance and Awareness Questionnaire; EC, Empathic Concern; FS, Fantasy Scale; PD, Personal Distress; RT, Reaction times.
Pearson/Spearman correlations of all measures (overall analyses).
| 1. RT incongruent trials | 0.89 | −0.14 | 0 | −0.14 | −0.21 | 0.19 | −0.37 |
| 2. RT congruent trials | − | −0.13 | −0.01 | −0.15 | −0.20 | 0.18 | −0.44 |
| 3. intensity | − | −0.68 | 0.21 | 0.02 | 0.15 | 0.40 | |
| 4. (Un)pleasantness | − | −0.22 | 0.07 | −0.28 | −0.22 | ||
| 5. PVAQ | − | 0.22 | 0.20 | 0.16 | |||
| 6. EC | − | 0.38 | 0.21 | ||||
| 7. FS | − | −0.02 | |||||
| 8. PD | − |
PVAQ, Pain Vigilance and Awareness Questionnaire; EC, Empathic Concern; FS, Fantasy Scale; PD, Personal Distress; RT, Reaction times.
p < 0.05;
p < 0.01.